pharmaceutical preparations for the treatment and prevention of irritable bowel syndrome, chronic idiopathic constipation, and opioid-induced constipation; pharmaceutical preparations for the treatment and prevention of hyperphosphatemia; pharmaceutical preparations for the treatment and prevention of constipating dysmotility disorders associated with Parkinson's disease and cystic fibrosis; pharmaceutical preparations for the treatment and prevention of hyperkalemia